EUVIMEDEUVIMED entdecken
Crossref

FDG PET Imaging Biomarker Associations with Survival Outcomes after Radiotherapy for Oligoprogressive NSCLC

F. Yaseen, D.S. Hippe, J. Kang, J. Zeng, S.R. Bowen

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e774-e775

DOI: 10.1016/j.ijrobp.2026.06.2333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von F. Yaseen und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yaseen, F., Hippe, D., Kang, J., Zeng, J., & Bowen, S. (2026). FDG PET Imaging Biomarker Associations with Survival Outcomes after Radiotherapy for Oligoprogressive NSCLC. International Journal of Radiation Oncology*Biology*Physics, 126(1), e774-e775. https://doi.org/10.1016/j.ijrobp.2026.06.2333

Vancouver

Yaseen F, Hippe D, Kang J, Zeng J, Bowen S. FDG PET Imaging Biomarker Associations with Survival Outcomes after Radiotherapy for Oligoprogressive NSCLC. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e774-e775. doi:10.1016/j.ijrobp.2026.06.2333

BibTeX
@article{Yaseen2026,
  author = {Yaseen, F. and Hippe, D.S. and Kang, J. and Zeng, J. and Bowen, S.R.},
  title = {FDG PET Imaging Biomarker Associations with Survival Outcomes after Radiotherapy for Oligoprogressive NSCLC},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {e774--e775},
  doi = {10.1016/j.ijrobp.2026.06.2333}
}
Kostenlos starten →